title: First case report of acute generalized exanthematous pustulosis due to labetalol.
authors.forename: E
authors.initials: E
authors.lastname: Gómez Torrijos
authors.forename: C
authors.initials: C
authors.lastname: García Rodríguez
authors.forename: M P
authors.initials: MP
authors.lastname: Sánchez Caminero
authors.forename: A
authors.initials: A
authors.lastname: Castro Jiménez
authors.forename: R
authors.initials: R
authors.lastname: García Rodríguez
authors.forename: F
authors.initials: F
authors.lastname: Feo-Brito
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D018674:Adrenergic Antagonists / Q000009:adverse effects* / Q000276:immunology; D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000276:immunology; D001262:Atenolol / Q000009:adverse effects / Q000276:immunology; D003429:Cross Reactions; D057915:Drug Substitution; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects* / Q000276:immunology; D010328:Patch Tests; D011237:Predictive Value of Tests; D011247:Pregnancy; D011263:Pregnancy Trimester, Third
chemical_list: D018674:Adrenergic Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol; D007741:Labetalol